| Term 
 | Definition 
 
        | pupil dilation, dec GI motility, inc HR & contractility, bronchial dilation, hepatic glucose release, vasoconstriction, inc coagulation, copious sweating |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | pupil constriction, inc GI secretions & motility, dec HR w/ dec force, bronchial constriction, glycogen stored |  | 
        |  | 
        
        | Term 
 
        | what parts of neurotransmitters can be modified by drugs? |  | Definition 
 
        | Synthesis, storage, release, inactivation |  | 
        |  | 
        
        | Term 
 
        | what are the ANS neurotransmitters? |  | Definition 
 
        | Acetylcholine, norepi, epi |  | 
        |  | 
        
        | Term 
 
        | Preganglionic neurotransmitter |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Parasympathetic postgangion neurotransmitter |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Sympathetic postganglion neurotransmitter |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | receptors respond to epi or NE |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alpha 1, Alpha 2, Beta 1, Beta 2 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | nicotinic N receptor subtype location |  | Definition 
 
        | all ANS ganglia and adrenal medulla |  | 
        |  | 
        
        | Term 
 
        | nicotinic N receptor response |  | Definition 
 
        | stimulate para and sympa postganglionic nerves, release epi from adrenal medulla |  | 
        |  | 
        
        | Term 
 
        | nicotinic M receptor subtype location |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | nicotinic M receptor response |  | Definition 
 
        | contraction of skeletal muscles |  | 
        |  | 
        
        | Term 
 
        | muscarinic receptor subtype location |  | Definition 
 
        | all para target organs: eye, heart, lung, bladder, GI tract, sex organs, sweat glands, blood vessels |  | 
        |  | 
        
        | Term 
 
        | muscarinic receptor subtype response |  | Definition 
 
        | Eye: miosis, near vision Heart: dec HR
 Lung: bronchial constriction, secretion promotion
 Bladder: voiding of bladder d/t relaxed sphincters and bladder pressure
 GI: salivation, inc secretions, inc intestinal tone and motility
 Sex organs: erection
 Blood Vessels: vasodilation
 |  | 
        |  | 
        
        | Term 
 
        | alpha 1 receptor location |  | Definition 
 
        | Eye, Arterioles, Viens, penis, prostate, bladder |  | 
        |  | 
        
        | Term 
 
        | alpha 1 response to receptor activation |  | Definition 
 
        | Eye: mydriasis Arterioles: constriction
 Veins: constriction
 Penis: ejaculate
 Prostate: contract
 Bladder: contract sphincter
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | beta 1 response to receptor activation |  | Definition 
 
        | Heart: inc HR, force of contraction, AV conduvtion Kidney: renin release
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Arterioles, Bronchi, Uterus, Liver, Skeletal muscles |  | 
        |  | 
        
        | Term 
 
        | beta 2 response to receptor activation |  | Definition 
 
        | Arterioles: dilation Bronchi: dilation
 Uterus: relaxation
 Liver: glycogenolysis
 Skeletal Muscle: enhanced contraction, glycogenolysis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | enzyme that breaks down ACh |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | inhibits enzyme that breaks down ACh so it increases activation of ACh receptors and prolong ACh activity |  | 
        |  | 
        
        | Term 
 
        | reversible anticholinesterase |  | Definition 
 
        | neostigmine, physostigmin |  | 
        |  | 
        
        | Term 
 
        | irreversible anticholinesterase |  | Definition 
 
        | organophosates (insecticides) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inc para effct smooth muscle, cardiac, exocrine glands & eyes 
 Results: salivation, sweating, inc GI tone and activity, bradycardia, miosis, vasodilation
 
 Uses: treat urinary retention or gastric distention, treat glaucoma
 
 Antidote is atropine
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | autoimmune process in which cholinergic receptors are destroyed by the immune system. Since receptors are damaged, we enhance ACh by stopping cholinesterase |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | use cholinergics to improve neurotransmission |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | inhibit action of ACh at postsynaptiv receptor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | allow SANS activity (fight or flight) |  | 
        |  | 
        
        | Term 
 
        | Anticholinergic drug of choice |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | treat bradycardia dec resp secretion pre-op
 dilate eyes
 reduce GI secretion & motility
 relieve biliary/renal colic
 *antidote to OD w/ cholinergics or organophosphates
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | dry mouth, eyes, nose blurred vision, photophobia
 urinary hesitance, retention
 constipation
 tachycardia & palpations
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | glaucoma, urinary retention, tachycardia, asthma |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | stimulates sympathetic nervous system |  | 
        |  | 
        
        | Term 
 
        | Adrenergic Agonist Effects |  | Definition 
 
        | inc HR & contractility Vasoconstriction, inc BP
 bronchodilation
 uterine relaxation
 Inc BG
 inc muscle tone, tremor
 pupillary dilation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Subsets of Adrenergic Agonists |  | Definition 
 
        | Catecholamines Noncatacholamines
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | RAPIDLY degraded by MAO & enzyme COMT = SHORT half life, 1st pass effect = not PO no crossing BBB
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | no breakdown by MAO or COMT = longer duration, ok for PO, crosses BBB |  | 
        |  | 
        
        | Term 
 
        | Whew, some catecholamine rush! |  | Definition 
 
        | Dr's response to saving kids life...inc HR, contractility, BG need, O2 need |  | 
        |  | 
        
        | Term 
 
        | Epinephrine (adrenergic Agonist) activation |  | Definition 
 
        | activates alpha 1,2 beta 1,2 dopamine & histamine = not specific |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | vasoconstriction, topical surface bleeding, nasal decongestion, inc BP, mydriasis 
 can cause tissue necrosis so careful IV use
 |  | 
        |  | 
        
        | Term 
 
        | Epi adverse effects on alpha 1 |  | Definition 
 
        | HTN, necrosis w/ IV, urinary retention |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | eh..not of clinical significance |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | inc HR & contractility = treat heart failure, cardiac arrest, shock |  | 
        |  | 
        
        | Term 
 
        | epi adverse effects on beta 1 |  | Definition 
 
        | tachycardia dysrhythmia
 angina
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | relax smooth muscle = bronchodilate & delay preterm labor |  | 
        |  | 
        
        | Term 
 
        | epi adverse effects on beta 2 |  | Definition 
 
        | hyperglycemia, tremor albuterol
 |  | 
        |  | 
        
        | Term 
 
        | effect of dopamine receptor activation |  | Definition 
 
        | renal vasodilation, urinary output |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | in shock states = elevates BP by vasoconstriction and improved CO while sparing kidneys |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | for acute allergic reaction vasoconstriction and bronchodilation immediately
 inc CO, block histamines
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Contraindications for epi use |  | Definition 
 
        | pts w/ tachycardia, high BP, etc |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | necrotic tissue, tachycardic pt, high BP |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MAOI (interact w/ everything), tricyclics |  | 
        |  | 
        
        | Term 
 
        | why is epi use limited in clinics? |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | alpha = phenylephrine (vasoconstrict, inc BP) beta = isoproterenol (activates beta 1, improve cardiac conduction, inc CO & activates beta 2, bronchodilation)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | vasodilate, dec BP, not given for HTN cerebral vasocontsriction alleviates migraines
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | END IN olol beta 1 = cardiac rate, contraction & conduction
 beta 2 = bronchioles & blood vessels
 non selective (propranolol)
 |  | 
        |  | 
        
        | Term 
 
        | what drug do you give during a heart attack? |  | Definition 
 
        | beta 1 blocker = dec HR & force of contraction, lower BP angina & MI, dec AV conduction, glaucoma |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | dec glycogenolysis, and tremor adverse effect = bronchoconstriction and hypoglycemia
 blocks renin release = lower BP
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Propranolol (non selective) lower BP in HTN
 performance anxiety
 dec HR in tachycardia
 dec chest pain in CAD/MI
 reduce tremor
 prevent migraines
 |  | 
        |  | 
        
        | Term 
 
        | cardioselective beta 1 blockers |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | beta blocker pharmacokinetics |  | Definition 
 
        | first pass, high protein binding, 1/2 life determines dosing frequency, lipid solubiliy = inc CNS side effects |  | 
        |  | 
        
        | Term 
 
        | beta blocker side effects |  | Definition 
 
        | bradycardia, hypotension, fatigue, lethargy, depression, sleep disturbance |  | 
        |  | 
        
        | Term 
 
        | which pts should you be cautious in beta blocker administration? |  | Definition 
 
        | diabetics, PVD, heart failure, asthma |  | 
        |  | 
        
        | Term 
 
        | where are cholinergic receptors located? |  | Definition 
 
        | entire parasympathetic system |  | 
        |  | 
        
        | Term 
 
        | where are adrenergic receptors located? |  | Definition 
 
        | sympathetic nervous system |  | 
        |  | 
        
        | Term 
 
        | Cholinergic activation (DUMBELS) |  | Definition 
 
        | defecation, urination, miosis (constriction), electrical changes (slows HR), lacrimations (secretion) |  | 
        |  | 
        
        | Term 
 
        | Anticholinestreases of note |  | Definition 
 
        | physostigmine (atropine antidote) neostigmine (tx myasthenia gravis)
 donepezil (aricept - enters CNS to inc ACh)
 |  | 
        |  | 
        
        | Term 
 
        | Anticholinergic (Atropine) uses |  | Definition 
 
        | treat bradycardia create pupillary dilation
 slow GI tract
 decrease secretions pre-op
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | blind as a bat red as a beet
 dry as a bone
 mad as a hatter
 hot as a hare
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | anticholinergic inhaled for respiratory problems causes bronchoconstriction
 |  | 
        |  | 
        
        | Term 
 
        | neuromuscular anticholinergic |  | Definition 
 
        | Paralytic - use in surgery, ER, ICU causes paralysis & hypotension
 pts LOA is the same, treat for pain
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | turbocurarine, succinylcholine, pancuronium |  | 
        |  | 
        
        | Term 
 
        | albuterol and levalbuterol uses |  | Definition 
 
        | beta 2 agonist, inhaled to cause bronchodilation |  | 
        |  | 
        
        | Term 
 
        | alpha adrenergic blockers of consequence |  | Definition 
 
        | Pazosin - anti HTN, treat BPH Terazosin - anti HTN, treat BPH
 Tamsulosin - treat BPH
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Nonselective Beta Blocker adverse reactions |  | Definition 
 
        | bradycardia, AV block, reduced CO, hypotension, fatigue, lethargy, bronchoconstriction, inhibition of glycogenolysis |  | 
        |  |